Chef du département d'urologie du centre médical Rambam, le Dr Amiel est spécialisé en oncologie urologique.
Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.
He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.
Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.
Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).
Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).
Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.
He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.
Member: Egyptian Cancer Society, ESTRO, ESMO.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Le Dr Joseba Rebollo Liceaga possède plus de 30 ans d'expérience en oncologie, se spécialisant dans le cancer des testicules à Quironsalud Torrevieja.
Le professeur Eduard Becht dirige une association interdisciplinaire d'uro-oncologie et possède plus de quatre décennies d'expérience.
Serkan Deveci est un professeur d'urologie dont les recherches portent principalement sur la fonction sexuelle des patients cancéreux. Il travaille à l'hôpital Medical Park Göztepe et a suivi une formation spécialisée en urologie aux États-Unis.
Le Dr Michael Van Kampen est un spécialiste de la radiothérapie dévoué à la clinique Nordwest, se concentrant sur les traitements de précision contre le cancer.
Voir le portfolio
Spécialisé en oncologie chirurgicale avec une expertise dans les cancers abdominaux et rétropéritonéaux, y compris le cancer du testicule.
Le Dr Topcu a suivi sa formation dans de prestigieux centres de cancérologie aux États-Unis et au Canada, apportant une expertise internationale aux cas de cancer du testicule.
Le Dr Bogdan est spécialisé dans la chirurgie urologique laser et mini-invasive, y compris les interventions pour le cancer du testicule au Dievo Surgery Center.
Spécialisé en radio-oncologie pour le cancer des testicules à l'hôpital Emsey, formé à l'université de Marmara.
Le Dr Tanriverdi est spécialisé en chirurgie urologique laparoscopique avancée et en uro-oncologie à l'hôpital Liv Ulus.
Le Dr Shalabh Agrawal est spécialisé dans le traitement du cancer du testicule au sein d'une équipe d'urologie renommée des hôpitaux Artemis.
Eslie Perez enseigne aux futurs médecins de l'hôpital régional de Puerto Vallarta tout en gérant son cabinet privé.